Trial Profile
Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Carboplatin (Primary) ; Everolimus (Primary) ; Temozolomide (Primary) ; Trametinib (Primary) ; Veliparib (Primary)
- Indications Solid tumours
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms MPACT
- 11 May 2022 Status changed from active, no longer recruiting to completed.
- 06 May 2021 Planned primary completion date changed from 5 May 2021 to 5 May 2022.
- 16 Jul 2020 Status changed from recruiting to active, no longer recruiting.